Endpoints News Editor John Carroll and SVB’s Nooman Haque once again will host a slate of panels and fireside chats to illuminate the latest on financing, R&D trends and regulatory issues that are central to drug development.
Joining the event will be our Co-founder, Rowan Gardner to meet with other prominent players in Europe’s biopharma industry and share high-resolution patient stratification insights from PrecisionLife.
Speak to Rowan at EUBIO22 to find out more about how our better understanding of disease biology is enabling new precision medicine opportunities for biopharma to develop more personalized treatments for patients with unmet medical needs in over 40 chronic diseases.
To see the agenda and register, visit the EUBIO22 website.